All North Carolina public schools, including public charter schools are required annually to report on the status of Health Assessments for those students who are enrolling for the first time in a North Carolina public or public charter school (§ 130A-441(c) PDF, and the immunization status of all students in kindergarten, seventh, and twelfth grade (G.S. 130A-155(c) PDF).
Topics Related to Immunization
This email is to inform you that the North Carolina Immunization Program (NCIP) has doses of 317 VFA ABRYSVO® vaccine available for order for non-Medicaid, uninsured pregnant women between 32 to 36 weeks of gestation during September through January, who are receiving services at the local health department.
Dear Local Health Departments,On Wednesday, Aug. 27, 2025, FDA approved the updated 2025-2026 COVID-19 vaccines and rescinded Emergency Use Authorizations (EUA) for previously authorized COVID-19 vaccines.
Dear Providers,On Wednesday, Aug. 27, 2025, FDA approved the updated 2025-2026 COVID-19 vaccines and rescinded Emergency Use Authorizations (EUA) for previously authorized COVID-19 vaccines.As a result of the 2024–2025 COVID-19 EUA rescissions, providers are required to stop using those vaccine products or presentations immediately. Any COVID-19 vaccine products that were authorized under an EUA should be removed from storage, removed in NCIR as wasted, and returned per routine NCIP vaccine wastage guidelines.
Click Here to Watch: Strategies to Effectively Discuss Childhood Vaccines WebinarThe North Carolina Department of Health and Human Services (NCDHHS) is excited to announce the release of our new educational webinar, housed within our Childhood Vaccine Toolkit.
This memo is to inform North Carolina Immunization Program (NCIP) providers of the availability of influenza vaccine and the ordering process for the 2025-2026 respiratory season. Please take time to carefully review this memo in full.
This email is to inform you of the final dates to submit orders for the 2024–2025 COVID-19 vaccine season. Based on vaccine shelf life and product availability, the last ordering dates are as follows:
Dear Local Health Department Partner,This email is to inform you that the North Carolina Immunization Program (NCIP) has additional 317 VFA funding to support MMR vaccine availability for Local Health Departments (LHDs). This supplemental funding expires at the end of September, or until funds are exhausted. MMR is routinely available to LHDs for uninsured eligible adults through the NCIP with 317 VFA funds. However, this additional, time-limited funding allows for an increased supply of MMR doses to support your vaccination efforts.
The purpose of this email is to remind VFC-enrolled providers that the monoclonal antibody product nirsevimab (trade name Beyfortus® manufactured by Sanofi) will be available for ordering on Friday, August 1, 2025.